An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
Biphasic coupled enzyme systems are increasingly utilised in industrial biotechnology, pharmaceutical synthesis, and environmental biocatalysis, where two or more enzymes act in concert across aqueous‑organic or aqueous‑aqueous two‑phase systems to drive reactions with enhanced efficiency, selectivity, or product yield. These systems often involve compartmentalised reactions, substrate shuttling, and cofactor regeneration, making them intrinsically more complex than monophasic single‑enzyme processes. The accurate and comprehensive characterisation of biphasic coupled enzyme systems—encompassing individual enzyme activities, coupling efficiency, interfacial enzyme distribution, substrate flux, and overall process stability—is essential for system design, process optimisation, quality control, and regulatory compliance. Our specialised detection platform offers a fully validated suite of biochemical, chromatographic, and biophysical assays tailored to biphasic coupled enzyme systems, delivering the high‑precision, actionable data that clients require for research, development, and industrial scale‑up.

Clients seeking biphasic coupled enzyme detection services are motivated by a range of strategic objectives. In biocatalysis and bioprocess development, the primary need is to quantify the individual and combined activities of the enzyme partners, to assess the efficiency of the coupling (e.g., the rate of substrate conversion to product), and to determine the impact of phase separation and interfacial effects on overall performance. In pharmaceutical and fine chemical manufacturing, monitoring enzyme activities in two‑phase systems (such as aqueous‑organic solvent mixtures) is critical for ensuring high conversion yields, enantioselectivity, and minimal by‑product formation. In environmental bioremediation, biphasic systems are used for the degradation of hydrophobic pollutants; characterising enzyme activities and stability in the presence of organic phases is essential for efficacy assessment. In quality control of enzyme products, verifying the activity and integrity of each enzyme component in the coupled system is necessary for batch‑release and for ensuring consistent performance. In regulatory submissions, comprehensive data on enzyme activities, coupling efficiency, and stability are required for the approval of new biocatalytic processes and products. Our service is architected to address these diverse needs with a flexible, ISO 17025‑accredited analytical framework that adapts to the specific enzyme combination, phase system, and client's regulatory or research context.
Our analytical platform comprises five interconnected modules that collectively deliver a comprehensive evaluation of biphasic coupled enzyme system quality and performance. The Individual Enzyme Activity Module employs a range of validated, substrate‑specific assays for each enzyme in the coupled system (e.g., chromogenic, fluorogenic, or HPLC‑based methods), performed in both the aqueous and organic phases where applicable. We determine the specific activity (U/mg protein) for each enzyme with precision within ±2% RSD and a limit of detection (LOD) as low as 0.001 U/mL. For detailed kinetic characterisation, we calculate Michaelis‑Menten parameters (Km, Vmax, kcat) for each enzyme under biphasic conditions, as well as the coupling efficiency (e.g., product formation per unit of cofactor consumed), with 95% confidence intervals typically within ±5%. The Interfacial and Partitioning Module uses phase partitioning experiments and interfacial tension measurements to assess enzyme distribution, and confocal microscopy (with fluorescently labelled enzymes) to visualise interfacial localisation. The Substrate Flux and Product Profiling Module employs UHPLC‑MS/MS to monitor the concentration of substrates, intermediates, and products in each phase over time, providing kinetic profiles and mass balance data with LOQs as low as 0.1 µM. The Stability and Deactivation Module subjects the coupled system to accelerated aging conditions (varying temperatures, pH, solvent concentrations, and shear stress) and monitors individual enzyme activities, coupling efficiency, and aggregate formation (by SEC‑HPLC) over time. Using Arrhenius modelling and deactivation kinetics, we predict system half‑life and identify the rate‑limiting component. The Contaminant and Compatibility Module screens for protease activity (which can degrade one or both enzymes), cofactor degradation, and interfacial denaturation, using activity assays and biophysical methods (e.g., CD spectroscopy). All modules are validated with reference coupled enzyme systems and include rigorous quality controls (system suitability, blank subtraction, and replicate analyses).
Our platform consistently delivers performance that surpasses typical industry and academic standards. In activity assays, we achieve signal‑to‑noise ratios > 200:1 at the LOD, with linearity over four orders of magnitude. Our kinetic fitting software uses global non‑linear regression to provide precise estimates of Km and Vmax, with residual errors < 2%. In product profiling, our high‑resolution LC‑MS/MS provides mass accuracy < 2 ppm and enables the identification of unexpected intermediates and by‑products with confidence scores > 95%. In stability studies, we apply accelerated degradation models that account for both first‑order and autocatalytic pathways, providing robust predictions of half‑life (t1/2) and activation energy (Ea) for the entire coupled system, as well as for each enzyme component. Additionally, we offer real‑time monitoring of enzyme activity in multiphase systems using custom‑built flow cells and in situ spectroscopic probes (e.g., Raman, mid‑IR) to capture dynamic behaviour without sampling artefacts. This multi‑layered approach ensures that our clients receive not only individual enzyme activity values but also a comprehensive understanding of the system's dynamic behaviour, limitations, and operational robustness.
Our service provides several unique benefits that directly address client challenges. First, we have developed matrix‑specific sample preparation protocols for a wide variety of biphasic systems—including aqueous‑organic, aqueous‑ionic liquid, and aqueous‑aqueous (polymer‑salt) phase systems—that effectively preserve enzyme activity and allow for separate analysis of each phase, achieving recoveries > 92% for all tested matrices. Second, we maintain a comprehensive reference library of common coupled enzyme pairs (e.g., alcohol dehydrogenase‑glucose dehydrogenase, kinase‑phosphatase, peroxidases‑oxidases) and their known kinetic and stability data, enabling rapid benchmarking and system design guidance. Third, we offer a rapid screening service using a microplate‑based coupled assay that provides semi‑quantitative coupling efficiency data within 2 hours of sample receipt—ideal for early‑stage system screening and optimisation. Fourth, our customised process simulation studies can mimic real‑world reaction conditions (including solvent gradients, substrate feeds, and continuous operation) and provide statistically robust recommendations for enzyme ratios, phase composition, and process parameters to maximise yield and longevity. Fifth, we provide integrated data interpretation that links individual enzyme activities, coupling efficiency, and stability to industrial performance metrics (e.g., product yield, productivity, biocatalyst lifetime), enabling clients to predict full‑scale performance without extensive pilot trials. Sixth, all our methods comply with ICH Q2(R1), OECD, and ISO 17025 guidelines, and we supply full validation dossiers (specificity, linearity, accuracy, precision, LOD, LOQ, robustness) along with detailed SOPs, ensuring that our data are readily accepted by regulatory authorities and customers. Our team of biocatalysis engineers, enzymologists, and analytical chemists provides consultative interpretation, helping clients to translate analytical findings into actionable improvements—for example, recommending optimal phase compositions to minimise enzyme deactivation, identifying the rate‑limiting enzyme for engineering, or designing effective cofactor recycling strategies.
Our reporting transforms analytical data into strategic operational knowledge. We deliver a comprehensive final report that includes: (i) an executive dashboard with key metrics (specific activity of each enzyme, coupling efficiency, product yield, system half‑life, and phase distribution) presented as concise scorecards; (ii) a detailed analytical section containing raw data, calibration curves, chromatograms, and kinetic fits; (iii) a statistical comparison of samples against reference systems or historical batches, with p‑values and confidence intervals; and (iv) an interpretive narrative that contextualises the results—for example, explaining how a high coupling efficiency indicates a well‑balanced system, or how a low interfacial enzyme activity suggests the need for surfactant optimisation. For clients with multiple system variants or process conditions, we provide multivariate analysis (PCA, PLS‑DA) to identify critical parameters and to guide system optimisation. We also offer predictive models that estimate reaction yield or system lifetime based on initial enzyme characteristics and process parameters, using our internally developed algorithms. All raw data files (e.g., .xlsx, .raw, .cdf) are supplied to ensure full transparency and re‑analysis capability.
The versatility of our biphasic coupled enzyme detection service spans a wide range of sectors. In industrial biotechnology and biocatalysis, our assays support the development of efficient multienzyme processes for the synthesis of chiral pharmaceuticals, flavours, and fragrances. In pharmaceutical manufacturing, we characterise coupled enzyme systems used in the production of drug intermediates and active ingredients. In environmental biotechnology, we assess enzyme performance for the degradation of organic pollutants in biphasic systems. In enzyme manufacturing, our purity and stability testing ensure product reliability and regulatory compliance. In academic research, our detailed kinetic and system‑level data support studies on enzyme synergy, phase‑interface phenomena, and biocatalyst engineering. In regulatory submissions, our validated data packages facilitate the approval of novel biocatalytic processes and products. Our ability to tailor the analytical package to the specific enzyme system, phase composition, and regulatory framework ensures that we serve both small research groups and large industrial enterprises with equal rigor and responsiveness.
We are dedicated to advancing biphasic enzyme analytics through continuous technological improvement. Our current R&D includes the development of microfluidic‑based two‑phase reactor systems for real‑time activity and flux monitoring, and the application of machine learning algorithms to predict optimal enzyme ratios and phase compositions from initial characterisation data. We actively participate in inter‑laboratory proficiency testing for enzyme activity and biocatalyst performance analysis, and we contribute to the development of standard reference materials for coupled enzyme systems. Our quality management system is ISO 9001 and ISO 17025 certified, and we follow GLP for all regulatory studies. We offer flexible engagement models—from single‑sample analysis to multi‑year collaborative projects—with dedicated project managers, volume discounts, and priority handling for time‑sensitive samples. Our global logistics provide specialised shipping kits (with stabilising buffers and temperature control) to preserve enzyme activity during transit. Turnaround times range from 2 business days for rapid activity screening to 14 business days for comprehensive kinetic, stability, and coupling‑efficiency profiling. We maintain open communication, providing preliminary results upon request and final reports with expert commentary. Our success is measured by the confidence our clients have in their processes and products. We invite you to partner with us to unlock the full potential of your biphasic coupled enzyme systems.
In summary, our biphasic coupled enzyme detection service delivers a comprehensive, precise, and application‑oriented analytical solution that integrates individual enzyme activity quantification, coupling efficiency assessment, phase distribution analysis, substrate flux monitoring, and stability evaluation. By combining advanced instrumentation with deep expertise in biocatalysis and process analytics, we empower our clients to optimise multienzyme processes, accelerate industrial biotransformation, and ensure product quality. We look forward to supporting your biphasic coupled enzyme analysis needs with our state‑of‑the‑art analytical platform.